BioStem Technologies Announces the Engagement of Investment Banking Firm Young America Capital for $15 Million Offering.

Biotech Investing

BioStem Technologies (OTC PINK: BSEM) announced the engagement of investment banking firm Young America Capital as an advisor for the Company’s upcoming $15 Million Reg D, 506(c) private placement offering. As quoted in the press release: “Over the past year, BioStem Tech has made impressive progress with the completion of our state of the art …

“Over the past year, BioStem Tech has made impressive progress with the completion of our state of the art biotech lab and the launch of our pharmaceutical division” said Henry Van Vurst, the Company’s CEO. “Given that progress, we believe that the time is right to engage an award winning investment banking advisory firm to help us secure the growth capital we need for the next stage of the Company’s development; and YAC’s track record in growth capital funding speaks for itself.”

Click here to read the full press release.

growth capital private placement us Biotech Investing